IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#2271
Positioning
Market Dominance
Manufacturing
Food Products
$276M
Jamaleddine Mustapha
N/A
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$UL UNILEVER PLC | 78 | 96 | 98 | 59 | - | - | 28.5% | 8.0% | 100.0% | 100.0% | 10.4% | -4.6% | 3.3% | 0.0x | $141.8B | VS | |
$ASML ASML HOLDING NV | 77 | 89 | 86 | 83 | - | - | 46.1% | 16.6% | 51.3% | 31.9% | 26.8% | -4.0% | 1.0% | 25.0x | $272.1B | VS | |
$ESLT ELBIT SYSTEMS LTD | 76 | 81 | 87 | 85 | - | - | 10.3% | 3.1% | 24.1% | 7.2% | 4.7% | 14.3% | 0.8% | 25.0x | $11.4B | VS | |
$MT ArcelorMittal | 75 | 71 | 98 | 85 | - | - | 2.2% | 1.5% | 9.3% | 5.3% | 2.2% | -8.5% | 2.2% | 16.0x | $18.9B | VS | |
$AMAT APPLIED MATERIALS INC /DE | 75 | 85 | 87 | 84 | 20.9x | 13.6x | 35.5% | 19.8% | 48.7% | 29.2% | 24.7% | 4.4% | 0.8% | 32.0x | $181.9B | VS | |
$SIMO Silicon Motion Technology CORP | 75 | 84 | 86 | 85 | - | - | 11.8% | 8.8% | 45.9% | 11.3% | 11.1% | 25.7% | 3.7% | 0.0x | $1.8B | VS | |
$CODA Coda Octopus Group, Inc. | 74 | 83 | 90 | 79 | 16.3x | 11.9x | 7.6% | 7.0% | 66.5% | 17.1% | 15.6% | 39.0% | 0.0% | 0.0x | $115M | VS | |
$GSK GSK plc | 74 | 84 | 90 | 70 | - | - | 22.6% | 4.9% | 71.2% | 12.8% | 9.4% | 1.7% | 5.9% | 124.0x | $72.1B | VS | |
$EFXT Enerflex Ltd. | 74 | 80 | 91 | 83 | - | - | 3.0% | 1.1% | 20.9% | 7.3% | 1.3% | 3.0% | 0.9% | 67.0x | $1.2B | VS | |
$BUD Anheuser-Busch InBev SA/NV | 74 | 84 | 97 | 63 | - | - | 8.2% | 3.5% | 55.3% | 25.9% | 12.4% | 0.7% | 1.7% | 0.0x | $87.0B | VS | |
$AFRI Forafric Global PLC | 48 | 40 | 40 | 49 | - | - | -135.3% | -38.0% | 10.0% | -2.8% | -8.5% | -9.2% | 0.0% | - | $276M | ||
| SECTOR BENCH | - | - | - | - | - | 22.3x | 11.5x | -2.5% | -0.1% | 42.5% | 1.3% | -0.2% | 5.9% | 0.0% | 0.2x | - | REF |
Forafric Global PLC (AFRI) receives a "Reduce" rating with a composite score of 48.4/100. It ranks #2271 out of 7,333 stocks in our coverage universe and carries a 2-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Direct cash return
Jamaleddine Mustapha
Chief Executive Officer
Labor Force
1
40
70
91
Audit Verdict: Average governance indicators based on financial metrics.
No recent insider transactions available for AFRI
In-line with peers — no strong momentum signal
Fair valuation relative to peers
Average quality profile
Low volatility — smoother ride and historically better risk-adjusted returns
Conservative, efficient capex — capital discipline signals management quality
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Manufacturing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
No analyst ratings for AFRI.
View All RatingsImproving capital utilization rates confirmed
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 40 | 17 | +23ALPHA |
| MOMENTUM | 49 | 37 | +12ALPHA |
| VALUATION | 40 | 18 | +22ALPHA |
| INVESTMENT | 70 | 100 | -30DRAG |
| STABILITY | 91 | 94 | -3NEUTRAL |
| SHORT INT | 18 | 3 | +15ALPHA |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROIC -9.4% vs WACC 10.5% (spread -19.9%)
GM 10% vs sector 43%, OM -3% vs sector 1%
Capital turnover 4.20x
Rev growth -9%, 3yr history
Interest coverage -0.6x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Forafric Global PLC receives a Reduce rating from our analysis, with a composite score of 48.4/100 and 2 out of 5 stars, ranking #2271 out of 7,333 stocks. AFRI's factor profile shows weakness across multiple dimensions, suggesting the stock may underperform going forward. Existing holders may want to consider trimming positions or tightening stop-losses.
AFRI's quality score of 40/100 is below average, suggesting challenges with profitability or capital efficiency. The company reports a return on equity of -135.3% (sector avg: -2.5%), gross margins of 10.0% (sector avg: 42.5%), net margins of -8.5% (sector avg: -0.2%). Investors should examine whether management is actively addressing these weaknesses or if they reflect structural industry headwinds.
With a value score of 40/100, AFRI appears somewhat expensive relative to its fundamentals. Investors paying a premium here are likely betting on above-average growth or margin expansion to justify current prices.
AFRI shows a solid investment score of 70/100, reflecting measured but productive capital allocation. Key growth metrics include revenue growth of -9.2% vs. a sector average of 5.9% and a return on assets of -38.0% (sector: -0.1%). This suggests the company is investing at an appropriate level to sustain growth without overextending its balance sheet.
AFRI is currently showing below-average momentum at 49/100, which may indicate weakening institutional interest or negative sentiment shifts. Revenue growth stands at -9.2% year-over-year, while a beta of 0.46 reflects its sensitivity to broader market moves. Investors should note that declining momentum can precede further price weakness, though contrarian opportunities sometimes emerge at these levels.
Forafric Global PLC earns an excellent stability score of 91/100, reflecting low price volatility and a conservatively managed balance sheet. Key stability metrics include a beta of 0.46. Stocks with this level of stability tend to act as portfolio anchors, providing downside protection during market corrections while still participating in broad market advances.
Forafric Global PLC's short interest score of 18/100 reveals significant bearish positioning, suggesting institutional investors are actively betting against the stock. Specific risk factors include micro-cap liquidity risk. At $276M (micro-cap), AFRI carries meaningful risk and is best suited for investors with high risk tolerance who have thoroughly evaluated the bear thesis.
Forafric Global PLC is a micro-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #2271 of 7,333 overall (69th percentile). Key comparisons include ROE of -135.3% trailing the -2.5% sector median and operating margins of -2.8% below the 1.3% sector average. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.
While AFRI currently exhibits a REDUCE profile, superior opportunities exist within the MANUFACTURING sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Manufacturing Alpha →Quant Factor Profile
Upgrade catalyst
Improvement in Short Int. (18) would have the largest impact on the composite score.
ROE 5356% ABOVE SECTOR MEDIAN (FAVORABLE)
Gross Margin 77% BELOW SECTOR MEDIAN
Op. Margin 319% BELOW SECTOR MEDIAN
AUDIT DATA AS OF DEC 31, 2024 (Q3 FY2024)
We rate Forafric Global PLC (AFRI) as a Reduce with a composite score of 48.4/100 at a current price of $9.90. The quantitative profile shows weakness across multiple dimensions, suggesting limited upside potential and elevated risk of underperformance relative to peers over the next 12 months.
The rating is primarily driven by strength in stability (91th percentile) and investment (70th percentile), which together account for the majority of the composite score. Offsetting weakness in value (40th percentile) and quality (40th percentile) tempers our overall conviction. We assign a No Moat rating (26/100), Medium uncertainty, and Poor capital allocation.
Key items to watch: the path to profitability. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
Forafric Global PLC holds a top-quartile position (#0 of 50) within the Manufacturing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 48.4/100 places it at rank #2271 in our full 7,333-stock universe. At $276M in market capitalization, Forafric Global PLC is a small-cap player in the Manufacturing space, which limits certain scale advantages but may allow for more agile strategic execution.
Revenue contraction of -9% combined with momentum at the 49th percentile paints a cautious picture of the near-term business outlook. The market appears to be pricing in continued challenges, and a catalyst for reversal is not clearly visible from current data.
The margin cascade tells an important story: gross margins of 10% (-32.5pp vs sector) narrow to operating margins of -3% (-4.1pp vs sector) and net margins of -8.5%, yielding a gross-to-net conversion rate of -85%. The significant margin erosion from gross to net suggests elevated operating expenses, high interest costs, or other structural drags that warrant monitoring.
At a current price of $9.90, Forafric Global PLC is trading at a premium to fundamental value. Our value factor score of 40/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. The premium valuation implies the market is pricing in significant future growth or quality improvements that are not yet fully reflected in current fundamentals.
The stock currently trades at P/S of 0.3x. We evaluate these multiples in the context of both absolute levels and sector-relative positioning to form our valuation view.
The stock may offer contrarian value if near-term headwinds prove transitory — the current weakness in factor scores may reverse if business fundamentals stabilize.
The Reduce rating (composite 48.4/100) reflects multi-factor weakness, and historically, stocks in this scoring range have underperformed the market by a meaningful margin.
Revenue decline of -9% signals business deterioration — declining revenues make it difficult to grow into the current valuation and often precede further negative revisions.
Thin net margins of -8.5% provide limited cushion against cost pressures, competitive pricing, or macroeconomic headwinds — even small changes in costs could swing the company to a loss.
We assign a Medium uncertainty rating to Forafric Global PLC. The stock presents a balanced risk profile: current negative profitability (net margin -8.5%) and low beta of 0.46 — while defensive, this may indicate limited upside participation in bull markets. While not risk-free, the core business fundamentals are adequate to withstand moderate economic stress, and the range of potential outcomes around our fair value estimate is manageable.
Specific risk factors that inform our assessment include: current negative profitability (net margin -8.5%); low beta of 0.46 — while defensive, this may indicate limited upside participation in bull markets. Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 91th percentile and quality factor at the 40th percentile provide a quantitative summary of the overall risk landscape.
Key risk mitigants include: above-average stability (91th percentile) suggests predictable business dynamics. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile is favorable for long-term investors.
We rate Forafric Global PLC's capital allocation as Poor. Key concerns include low returns on equity (-135.3%), negative profitability, weak asset returns (ROA -38.0%). Exemplary capital allocators generate ROE above 20% and maintain conservative leverage — Forafric Global PLC significantly underperforms these benchmarks, raising questions about management's ability to create shareholder value.
Investors should scrutinize management's reinvestment decisions and balance sheet trajectory before committing capital. Poor capital allocation often compounds over time: overlevered balance sheets limit strategic flexibility, while low returns on capital destroy shareholder value. We would need to see sustained improvement in profitability metrics and balance sheet discipline before considering an upgrade.
In summary, Forafric Global PLC receives a Reduce rating with a composite score of 48.4/100 (rank #2271 of 7,333). Our quantitative framework assigns a No Moat (26/100, trend: stable), Medium uncertainty, and Poor capital allocation. The average factor score across quality, value, momentum, stability, and investment is 58/100.
Our analysis does not support a constructive view on Forafric Global PLC at this time. The combination of limited competitive advantages, medium uncertainty, and poor capital allocation suggests unfavorable risk-reward at current levels. We recommend investors avoid new positions and existing holders consider reducing exposure.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We do not assign Forafric Global PLC a meaningful economic moat, scoring 26/100 on our composite assessment. The ROIC-WACC spread of -19.9% is the primary signal of economic value creation. Current fundamentals do not demonstrate the kind of durable competitive advantages — such as superior returns on invested capital, margin superiority, or reinvestment efficiency — that would protect the company from competitive erosion over the long term. The highest-scoring pillar, reinvestment efficiency, reached only 10/20.
The strongest moat sources are reinvestment efficiency (10/20) and margin superiority (6.9/20). Capital turnover 4.20x. GM 10% vs sector 43%, OM -3% vs sector 1%. These pillars form the core of Forafric Global PLC's competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include economic value creation (1.5/20) and financial resilience (2.5/20). ROIC -9.4% vs WACC 10.5% (spread -19.9%). Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect Forafric Global PLC's moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include declining revenues (-9%) that pressure the earnings outlook. The margin cascade from 10% gross to -3% operating to -8.5% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that profit quality is adequate though not exceptional, with the quality factor at the 40th percentile.
The margin profile shows gross margins of 10%, operating margins of -3%, net margins of -8.5%. Return metrics include ROE of -135.3% and ROA of -38.0%. Relative to the Manufacturing sector, gross margins are 32.5 percentage points below the sector median of 43%, and ROE of -135.3% compares to a sector median of -2.5%.
The balance sheet reflects revenue growth of -9%. Overall balance sheet health is adequate for the current business environment.
Above 50MA
37.18%
Net New Highs
+51081
For many investors, the main point of stock picking is to generate higher returns than the overall market. But the risk...
Forafric Global ( NASDAQ:AFRI ) Full Year 2024 Results Key Financial Results Revenue: US$274.2m (down 10% from FY...

U.S. stocks traded lower midway through trading, with Dow Jones dropping over 300 points on Tuesday. The Dow traded down 0.96% to 33,969.42 while the NASDAQ fell 0.74% to 13,588.13. The S&P 500, also fell, dropping, 0.80% to 4,374.24. Check This Out: Tesla, Nvidia And 2 Other Stocks Insiders Are Selling Leading and Lagging Sectors Consumer staples shares fell by just 0.2% on Tuesday. Meanwhile, top gainers in the sector included MamaMancini's Holdings, Inc. (NASDAQ: MMMB), up 4%, and Forafric Global PLC (NASDAQ: AFRI), up 6%. In trading on Tuesday, energy shares dipped by 2.5%. Top Headline Housing starts in the US surged 21.7% month-over-month to an annualized rate of 1.631 million in May. Building permits rose by 5.2% to an annual rate of 1.491 million in May. Equities Trading UP DICE Therapeutics, Inc. (NASDAQ: DICE) shares shot up 37% to $46.45 after Eli Lilly agreed to acquire the company for $48 per share in cash. Shares of VCI Global Limited (NASDAQ: VCIG) got a boost, shooting 79% to $5.07 after the company announced it has been appointed by Cogia GmbH to distribute its AI-based "Socializer Messenger". BranchOut Food Inc. (NASDAQ: BOF) shares were also up, gaining 22% to $5.40 after the company announced ...

Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday. Onion Global Limited (NYSE: OG) gained 113.9% to $0.8556. ChemoCentryx, Inc. (NASDAQ: CCXI) gained 110% to $50.68 after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share in cash. Minerva Neurosciences, Inc. (NASDAQ: NERV) jumped 80% to $4.8300. Greenpro Capital Corp. (NASDAQ: GRNQ) rose 61.1% to $2.82 after climbing around 14% on Tuesday after climbing 28% on Wednesday. Missfresh Limited (NASDAQ: MF) shares surged 59.3% to $0.1834 after dropping 7% on Wednesday. Quhuo Limited (NASDAQ: QH) gained 51.8% to $0.4966. Yellow Corporation (NASDAQ: YELL) rose 44.1% to $6.79 after the company swung to a profit for the second quarter. Society Pass Incorporated (NASDAQ: SOPA) gained 42.8% to $2.6700 after reporting 2Q 2022 and 1H 2022 financial results. GreenLight Biosciences Holdings (NASDAQ: GRNA) shares gained 39.6% to $4.55 after jumping over 25% on Wednesday. Samsung Biologics and the company recently announced the completion of the first commercial-scale engineering run for the companies' mRNA production partnership. ZW Data Action Technologies Inc. (NASDAQ: CNET) surged 37.5% to $0.79. ZW Data Action Technologies recently collaborated with Forbes Global Alliance to build the Forbes China Group Digital Collection Platform to launch NFT Products and jointly operate the platform data. Global Blood Therapeutics, Inc. (NASDAQ: GBT) rose 36.5% to $46.31 following a report suggesting the company is attracting takeover interest. According to a Bloomberg report, citing people familiar with the matter, some large pharmaceutical companies are looking into a potential deal. Legacy Housing Corporation (NASDAQ: LEGH) rose 29.9% to $17.55. Legacy Housing will restate its 1st, 2nd, 3rd quarters unaudited interim financial statements for FY21, Reuters reported. Forge Global Holdings, Inc. (NYSE: FRGE) jumped 27.8% to $5.82. Forge Global is expected to report Q2 financial results on August 11, 2022. Molecular Data Inc. (NASDAQ: MKD) gained 26.3% to $0.7701. Waitr Holdings Inc. (NASDAQ: WTRH) surged 26% to $0.4267. BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) gained 25.5% to $14.00 after the company reported better-than-expected Q2 EPS and sales results. The company also announced the FDA has lifted its partial clinical hold on the BCX9930 program. Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares rose 25.5% to $0.1418 after gaining around 9% on Wednesday. Immunic, Inc. (NASDAQ: IMUX) gained 25% to $4.89 following Q2 results. NanoViricides, Inc. (NYSE: NNVC) jumped 23.5% to $3.04 after the company announced it has begun drug development to combat Monkeypox virus. Exela Technologies, Inc. (NASDAQ: XELA) rose 20.5% to $1.7594 after the company announced an update on its capital deployment strategy. Exela Technologies says the company has purchased $70 million of face value 2026 Senior Secured Notes at a discount with funds raised from equity. This will be the first contribution to the company's STS ("Serve the Shareholders") initiative. Ashford Inc. (NYSE: AINC) gained 20.1% to $16.78 following Q2 earnings. Staffing 360 Solutions, Inc. (NASDAQ: STAF) surged 20% to $3.8462. Synthetic Biologics, Inc. (NYSE: SYN) rose 19.4% to $1.77. Synthetic Biologics recently announced a $3 million private placement of convertible preferred stock. Eloxx Pharmaceuticals, Inc. (NASDAQ:

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping more than 1% on Friday. The Dow traded down 0.58% to 30,783.52 while the NASDAQ fell 1.21% to 11,412.50. The S&P 500 also fell, dropping, 0.92% to 3,865.50. Also check this: Volatility In Markets Increases As Nasdaq Tumbles 200 Points Leading and Lagging Sectors Consumer staples shares slipped by just 0.1% on Friday. Meanwhile, top gainers in the sector included Forafric Global PLC (NASDAQ: AFRI), up 5% and BJ's Wholesale Club Holdings, Inc. (NYSE: BJ) up 3%. In trading on Friday, industrials shares fell by 2.9%. Top Headline FedEx Corp (NYSE: FDX) issued preliminary results. The company said it now expects first-quarter revenue of approximately $23.2 billion and first-quarter adjusted earnings to be around $3.44 per share. FedEx has withdrawn its fiscal year 2023 earnings forecast. The company expects business conditions to weaken further in the second quarter. Equities Trading UP Applied Optoelectronics, Inc. (NASDAQ: AAOI) shares shot up 49% to $3.7187 after the company announced the sale of its Chinese manufacturing facilities to Yuhan Optoelectronic Technology for $150 million. Shares of JanOne Inc. (NASDAQ: JAN) got a boost, ...